EirGenix Inc Sustainability Reports
EirGenix Inc. operates as a biopharmaceutical contract development and manufacturing organization (CDMO) providing end-to-end services from cell line development to large-scale cGMP manufacturing. It also develops its own proprietary pipeline of biologics and biosimilars primarily targeting oncology treatments.
Sector: Manufacturing
Country: Taiwan
Exchange: Taiwan Stock Exchange
FIGI: BBG004PWG3H1
4 reports from 2021 to 2024
